News | ASTRO | November 03, 2023

ASTRO recently issued the following statement on the Nov. 2 2024 Medicare PFS final rule, which includes an additional 2% cut for radiation therapy

ASTRO recently issued the following statement on the Nov. 2 2024 Medicare PFS final rule, which includes an additional 2% cut for radiation therapy

Getty Images


November 3, 2023 —The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M. Michalski, MD, MBA, FASTRO, Chair of the ASTRO Board of Directors, in response to the final 2024 Medicare Physician Fee Schedule (MPFS) released today by the Centers for Medicare and Medicaid Services (CMS): 

“ASTRO is deeply disappointed that CMS finalized an additional 2% cut to reimbursement for radiation therapy in today’s MPFS final rule. The consistent decline in Medicare reimbursement for radiation oncology threatens to undermine patients’ access to vital cancer care across the country. The time has come for Congress to intervene with reform legislation to ensure short-term stability and long-term viability. 

The additional cuts finalized today ensure that radiation oncology Medicare physician payments will have dropped by 25% from 2013 to 2024, more than nearly all other medical specialties. The continued trend of reduced reimbursement further underscores the critical need for a legislative fix for radiation oncology payments. 

Earlier this year, ASTRO introduced the Radiation Oncology Case Rate (ROCR) legislative proposal, a pivotal step toward ensuring that Americans have access to essential cancer care close to home. ROCR would create a new Medicare payment system for radiation oncology that is based on the value of the care provided, rather than the volume of services, offering an innovative path to achieving stable payments, enhancing the quality of care, reducing health disparities and lowering costs for both patients and Medicare. 

ASTRO also supports several legislative efforts designed to address shortcomings in the Medicare physician fee schedule, including: 

  • Providing Relief and Stability for Medicare Patients Act (H.R. 3674), introduced by Reps. Gus Bilirakis (R-FL), Tony Cardenas (D-CA), Greg Murphy, MD (R-NC) and Danny Davis (D-IL) to provide targeted relief to office-based specialists most effected by implementation of recent clinical labor price updates; 
  • Strengthening Medicare for Patients and Providers Act (H.R. 2474), introduced by Reps. Larry Bucshon, MD (R-IN), Raul Ruiz, MD (D-CA), Mariannette Miller-Meeks, MD (R-IA) and Ami Bera, MD (D-CA) to tie Medicare physician payment to inflation, as measured by the Medicare Economic Index; and 
  • Provider Reimbursement Stability Act (discussion draft), released by the GOP Doctors Caucus to update the MPFS budget neutrality threshold, address budget neutrality corrections for overestimates and underestimates in utilization, provide timely updates in direct costs used to calculate practice expenses and limit year-to-year variation in the physician payment conversion factor. 

ASTRO is determined to work Congress and CMS to secure the long-term stability needed for radiation oncologists to continue to deliver cutting-edge cancer care and maintain a strong focus on the value that we provide to our patients.” 

For more information: www.astro.org 


Related Content

News | ASTRO

Oct. 5, 2026 — The American Society for Radiation Oncology (ASTRO) recognized the recipients of its 2026 Gold Medal ...

Time October 07, 2026
arrow
News | Radiopharmaceuticals and Tracers

Oct. 5, 2026 — GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a U.S.-based CMO for PET ...

Time October 06, 2026
arrow
News | Radiation Therapy

Oct. 1, 2026 — At ASTRO 2026 Elekta highlighted new data showing unprecedented long-term survival outcomes for patients ...

Time October 05, 2026
arrow
News | ASTRO

Sept. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has named Siemens Healthineers the inaugural ...

Time September 29, 2026
arrow
News | Proton Therapy

Sept. 28, 2026 — Penn Medicine and Ion Beam Applications (IBA) have formed Noventra Oncology Alliance, a new joint ...

Time September 28, 2026
arrow
News | ASTRO

Sept. 22, 2026 — Leading experts in radiation therapy from the Abramson Cancer Center (ACC) of the University of ...

Time September 24, 2026
arrow
News | Molecular Imaging

Sept. 22, 2026 — Blue Earth Diagnostics, a part of the Bracco Group, has announced new research examining how precision ...

Time September 23, 2026
arrow
News | ASTRO

Sept.16, 2026 — For appropriately selected patients with muscle-invasive bladder cancer, preserving the bladder can be a ...

Time September 17, 2026
arrow
News | Information Technology

Sept. 16, 2026 — ETHERFAX, a provider of secure document exchange and cloud faxing, has expanded its solution suite with ...

Time September 16, 2026
arrow
News | Radiology Imaging

Sept. 1, 2026 — Leo Cancer Care and GE HealthCare have announced that the two companies intend to work together on GE ...

Time September 11, 2026
arrow
Subscribe Now